Potential Mechanisms Linking GLP-1 Therapy to Musculoskeletal Discomfort If leg cramps or muscle pain occur during GLP-1 therapy, several biological pathways may contribute
It may also reduce the risk of major cardiovascular events such as heart attack and stroke in people with type 2 diabetes and established cardiovascular disease
The therapeutic paradigm is multifaceted
The goal should be preserving the muscle, skeletal strength, and physical capability that allow you to stay active for decades to come
A patient picks a visit reason, creates an account, confirms contact information, decides on insurance or self-pay, and puts a card on file to book
NLRP3, recombinant NLR Family, pyrin domain containing protein 3